Abstract:Cardiovascular disease (CVD) is the most prominent cause of death of adults in the United States with coronary artery disease being the most common type of CVD. Following a myocardial event, the coronary endothelium plays an important role in the recovery of the ischemic myocardium. Specifically, endothelial cells (EC) must be able to elicit a robust angiogenic response necessary for tissue revascularization and repair. However, local or distant cues may prevent effective revascularization. Extracellular vesicles (EV) are produced by all cells and endothelium is a rich source of EVs that have access to the main circulation thereby potentially impacting local and distant tissue function. Systemic inflammation associated with conditions such as obesity as well as the acute inflammatory response elicited by a cardiac event can significantly increase the EV release by endothelium and alter their miRNA, protein or lipid cargo. Our laboratory has previously shown that EVs released by adipose tissue endothelial cells exposed to chronic inflammation have angiostatic effects on naïve adipose tissue EC in vitro. Whether the observed effect is specific to EVs from adipose tissue endothelium or is a more general feature of the endothelial EVs exposed to pro-inflammatory cues is currently unclear. The objective of this study was to investigate the angiostatic effects of EVs produced by EC from the coronary artery and adipose microvasculature exposed to pro-inflammatory cytokines (PIC) on naïve coronary artery EC. We have found that EVs from both EC sources have angiostatic effects on the coronary endothelium. EVs produced by cells in a pro-inflammatory environment reduced proliferation and barrier function of EC without impacting cellular senescence. Some of these functional effects could be attributed to the miRNA cargo of EVs. Several miRNAs such as miR-451, let-7, or miR-23a impact on multiple pathways responsible for proliferation, cellular permeability and angiogenesis. Collectively, our data suggests that EVs may compete with pro-angiogenic cues in the ischemic myocardium therefore slowing down the repair response. Acute treatments with inhibitors that prevent endogenous EV release immediately after an ischemic event may contribute to better efficacy of therapeutic approaches using functionalized exogenous EVs or other pro-angiogenic approaches.

Indoxyl Sulfate-Induced Extracellular Vesicles Released from Endothelial Cells Stimulate Vascular Smooth Muscle Cell Proliferation by Inducing Transforming Growth Factor-Beta Production

Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia

Uremic Toxin Indoxyl Sulfate Induces Dysfunction of Vascular Smooth Muscle Cells Via Integrin-Β1/erk Signaling Pathway.

VEGF Regulates FGF-2 and TGF-β1 Expression in Injury Endothelial Cells and Mediates Smooth Muscle Cells Proliferation and Migration

Plasma Small Extracellular Vesicle-Carried Mirna-501-5p Promotes Vascular Smooth Muscle Cell Phenotypic Modulation-Mediated In-Stent Restenosis.

Tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) Regulate the Proliferation and Migration of Vascular Smooth Muscle Cells by Interfering Ang II-Induced Human Umbilical Vein Endothelial Cells Derived EVs Delivering RNAs to VSMCs in the Co-culture Model.

Different Effects of Endothelial Extracellular Vesicles and LPS-Induced Endothelial Extracellular Vesicles on Vascular Smooth Muscle Cells: Role of Curcumin and Its Derivatives

MiR155-5p in Adventitial Fibroblasts-Derived Extracellular Vesicles Inhibits Vascular Smooth Muscle Cell Proliferation Via Suppressing Angiotensin-Converting Enzyme Expression

Effect and Mechanism of Phenotypic Transformation of Vascular Smooth Muscle Cells Regulated by TGF-β2 on the Venous Thrombus Wall Remodeling

Small Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhanced Proangiogenic Potential of Cardiac Fibroblasts via Angiopoietin-Like 4

The Protective Effects of Tripeptides VPP and IPP Against Small Extracellular Vesicles from Angiotensin II-Induced Vascular Smooth Muscle Cells Mediating Endothelial Dysfunction in Human Umbilical Vein Endothelial Cells.

Platelet-Derived Extracellular Vesicles Increase Col8a1 Secretion and Vascular Stiffness in Intimal Injury

Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells

Shear Stress and Vascular Smooth Muscle Cells Modulate the Proliferation of Endothelial Cells Via TGFβ1 and P-Akt Pathways

The Interaction of IGF-1/IGF-1R and Hydrogen Sulfide on the Proliferation of Mouse Primary Vascular Smooth Muscle Cells.

Evodiamine Inhibits Pdgf-Bb-Induced Proliferation of Rat Vascular Smooth Muscle Cells Through the Suppression of Cell Cycle Progression and Oxidative Stress

Pathogenesis of cardiovascular disease: Regulation of extracellular signal-regulated kinase on angiotensin II-induced proliferation of vascular smooth muscle cells

Macrophage Foam Cell-Derived Extracellular Vesicles Promote Vascular Smooth Muscle Cell Migration and Adhesion.

WITHDRAWN: Smooth Muscle Cell-Specific Knockout of Interferon Gamma (Ifn-Γ) Receptor Attenuates Intimal Hyperplasia Via STAT1-KLF4 Activation

Endothelial cell-derived extracellular vesicles impair the angiogenic response of coronary artery endothelial cells

Urotensin II Stimulates Vascular Endothelial Growth Factor Secretion from Adventitial Fibroblasts in Synergy with Angiotensin II